S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer
Randomized Trial of Post-Mastectomy Radiotherapy in Stage II Breast Cancer in Women With One to Three Positive Axillary Nodes Phase III
Sponsor: American College of Surgeons
A PHASE3 clinical study on Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by American College of Surgeons and has accumulated 7 data snapshots since 2000. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
May 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — May 2023 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Jun 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American College of Surgeons
- Cancer and Leukemia Group B
- Eastern Cooperative Oncology Group
- NCIC Clinical Trials Group
- NSABP Foundation Inc
- National Cancer Institute (NCI)
- North Central Cancer Treatment Group
- Radiation Therapy Oncology Group
- SWOG Cancer Research Network
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Hamilton, Canada